GUSTAVO NADER MARTA
Médico radio-oncologista do Hospital Sírio-Libanês e do Instituto do Câncer do Estado de São Paulo - Faculdade de Medicina da Universidade de São Paulo (FMUSP).
Doutor pelo programa de Oncologia da Faculdade de Medicina da Universidade de São Paulo (FMUSP)
Secretário Geral da Sociedade Brasileira de Radioterapia e Sociedade Brasileira de Radiocirurgia
Doutor pelo programa de Oncologia da Faculdade de Medicina da Universidade de São Paulo (FMUSP)
Secretário Geral da Sociedade Brasileira de Radioterapia e Sociedade Brasileira de Radiocirurgia
Check the activity agenda
Friday, March 22, 2024
• Room 1
08:15-10:30
SESSION 1: INTRODUCTION AND CLASSIFICATION
Opening
The 2021 WHO Classification for brain tumors: what is new?
Maximizing resection in glioma surgery: tricks and challenges of iUS and 5-ALA
Advancements in Treating Primary CNS Lymphomas: A Comprehensive Overview
The role of GammaTile therapy for gliomas
Sponsored by Varian:Today's multi-target treatment: How to be efficient with the precision
Discussion
Moderator: Beatriz Sartori (SP)
Moderator: Manoel Antonio de Paiva (Brasil)
Moderator: Camilla Yamada (SP)
Opening
Presenter: Marcos Maldaun (SP)
Presenter: Gustavo Nader Marta (SP)
The 2021 WHO Classification for brain tumors: what is new?
Speaker: Carmen Lucia Penteado Lancellotti (SP)
Maximizing resection in glioma surgery: tricks and challenges of iUS and 5-ALA
Speaker: Francisco Martínez Ricarte (Espanha)
Advancements in Treating Primary CNS Lymphomas: A Comprehensive Overview
Speaker: Tracy Batchelor (Estados Unidos)
The role of GammaTile therapy for gliomas
Speaker: Sujit Prabhu (Estados Unidos)
Sponsored by Varian:Today's multi-target treatment: How to be efficient with the precision
Speaker: Ernesto Roesler (PE)
Discussion
Monday, March 23, 2024
• Room 1
15:50-17:30
PLENARY SESSION 4
Medulloblastoma treatment in children and adolescents: From radiogenomics to molecular biology
Intracranial Germ cell tumors: North American or European, What is the best approach?
Immunotherapy in gliomas: is there a path ahead?
Oncolytic viruses for treatment of gliomas
Is Vorasidenib a real deal for IDHmt gliomas?
Moderator: Tomas de Andrade Lourencao Freddi (SP)
Moderator: Gustavo Nader Marta (SP)
Moderator: Olavo Feher (SP)
Medulloblastoma treatment in children and adolescents: From radiogenomics to molecular biology
Speaker: Vijay Ramaswamy (Canadá)
Intracranial Germ cell tumors: North American or European, What is the best approach?
Speaker: Mohamed Shebl Abdelbaki (Estados Unidos)
Immunotherapy in gliomas: is there a path ahead?
Speaker: Andreas Hottinger (Suíça)
Oncolytic viruses for treatment of gliomas
Speaker: Frederick F. Lang (Estados Unidos)
Is Vorasidenib a real deal for IDHmt gliomas?
Speaker: Andreas Hottinger (Suíça)
17:30-18:30
Oral Presentations
Discussant: Olavo Feher (SP)
Discussant: Tomas de Andrade Lourencao Freddi (SP)
Discussant: Gustavo Nader Marta (SP)
Discussant: Cleiton Formentin (SP)
Absracts Awards
Acknowledgement and Closure
Promoted by
Organization
Tourism agency
SILVER SPONSOR
BRONZE SPONSOR
SUPPORT SPONSOR
Institutional Support
